association id |
FEATURE |
Drug id |
Propr |
Public |
Drug Name |
Drug Target |
N FEATURE pos |
N FEATURE neg |
log max Conc tested |
FEATURE neg logIC50 MEAN |
FEATURE pos logIC50 MEAN |
FEATURE deltaMEAN IC50 |
FEATURE IC50 effectSize |
FEATURE neg Glass delta |
FEATURE pos Glass delta |
ANOVA FEATURE pval |
Tissue ANOVA pval |
MSI ANOVA pval |
ANOVA FEATURE FDR % |
a322 |
gain_cnaPANCAN84_(FGFR1,WHSC1L1) |
266 |
1 |
1 |
Zibotentan, ZD4054 |
Endothelin A Receptor |
68 |
851 |
3 |
5.46 |
5.8 |
0.348 |
0.62 . |
0.61 . |
0.73 . |
2.89e-04 |
1.47e-49 |
1.86e-01 |
15 |
a420 |
gain_cnaPANCAN84_(FGFR1,WHSC1L1) |
178 |
1 |
1 |
BAY 61-3606 |
SYK |
65 |
804 |
2.08 |
2.11 |
3.05 |
0.944 |
0.63 . |
0.63 . |
0.64 . |
5.15e-04 |
1.46e-16 |
3.62e-03 |
20 |
a427 |
gain_cnaPANCAN84_(FGFR1,WHSC1L1) |
207 |
1 |
1 |
AS601245 |
JNK |
64 |
805 |
2.08 |
2.18 |
2.8 |
0.623 |
0.54 . |
0.55 . |
0.47 |
5.23e-04 |
4.19e-06 |
2.02e-02 |
20 |
a446 |
gain_cnaPANCAN84_(FGFR1,WHSC1L1) |
133 |
1 |
1 |
Doxorubicin |
DNA intercalating |
65 |
807 |
0.0237 |
-1.82 |
-0.961 |
0.86 |
0.52 . |
0.52 . |
0.5 |
5.71e-04 |
5.28e-05 |
5.89e-02 |
21 |
a511 |
gain_cnaPANCAN84_(FGFR1,WHSC1L1) |
194 |
1 |
1 |
AUY922 |
HSP90 |
65 |
798 |
-1.36 |
-2.97 |
-2.1 |
0.867 |
0.55 . |
0.57 . |
0.44 |
7.56e-04 |
5.68e-10 |
4.78e-02 |
24 |